Key points are not available for this paper at this time.
analysis concludes that the proposed vaccine will induce a strong immune response against MPXV infection, making it a promising target for additional experimental trials.Communicated by Ramaswamy H. Sarma.
Ullah et al. (Wed,) studied this question.